"Our team of physicians and caregivers work to humanize your treatment and demystify the journey that is cancer. We are committed to listening to your concerns, answering your questions, and supporting you and your loved ones through every step of your cancer treatment. Our staff is also multilingual to assist both English and Spanish speakers with ease and the attention they deserve. We invite you to meet our providers and tour our facility to learn more."

During the past decade, Valley View Hospital Cancer Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 25 clinical trials were completed, i.e. on average, 312.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Valley View Hospital Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "SWOG Cancer Research Network" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "NRG Oncology" with 2 trials sponsored and "Novartis Pharmaceuticals" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Valley View Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Valley View Hospital Cancer Center" are "Breast Cancer" (6 trials), "Prostate Cancer" (4 trials), "Breast Ductal Carcinoma In Situ" (2 trials), "Clear Cell Renal Cell Carcinoma" (2 trials) and "Invasive Breast Carcinoma" (2 trials). Many other conditions were trialed in "Valley View Hospital Cancer Center" in a lesser frequency.

Most popular intervention types in "Valley View Hospital Cancer Center" are "Drug" (29 trials), "Other" (18 trials), "Biological" (16 trials), "Radiation" (7 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Bevacizumab" (7 trials), "docetaxel" (4 trials), "Cisplatin" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Valley View Hospital Cancer Center" are 20 trials for "All" genders, 8 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Valley View Hospital Cancer Center". undefined are not yet recruiting, 1 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Valley View Hospital Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Valley View Hospital Cancer Center, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".